NEW YORK (GenomeWeb News) – SomaLogic has raised $10 million in equity financing, the company said in a document filed with the US Securities and Exchange Commission on Tuesday.
The Boulder, Colo.-based protein biomarker discovery and clinical diagnostics company declined to comment on the financing. In its Form D document, it said that it had one investor in the round but did not identify the investor. SomaLogic did not say how proceeds will be used.
The privately held firm raised $19.5 million in 2003 in a Series C private financing round. In 2009, it received a $15 million investment from Quest Diagnostics as part of a diagnostic development deal, and in late 2003, SomaLogic received two investments totaling $11 million from two Japanese firms.
Last week, the company and Agilent Technologies announced a deal to expand SomaLogic's SOMAscan protein biomarker discovery platform.